104 related articles for article (PubMed ID: 35532796)
1. Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability.
Hatzimanolis A; Foteli S; Stefanatou P; Ntigrintaki AA; Ralli I; Kollias K; Nikolaou C; Gazouli M; Stefanis NC
Eur Arch Psychiatry Clin Neurosci; 2022 Oct; 272(7):1219-1228. PubMed ID: 35532796
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia.
Gracias J; Orhan F; Hörbeck E; Holmén-Larsson J; Khanlarkani N; Malwade S; Goparaju SK; Schwieler L; Demirel İŞ; Fu T; Fatourus-Bergman H; Pelanis A; Goold CP; Goulding A; Annerbrink K; Isgren A; Sparding T; Schalling M; Yañez VAC; Göpfert JC; Nilsson J; Brinkmalm A; Blennow K; Zetterberg H; Engberg G; Piehl F; Sheridan SD; Perlis RH; Cervenka S; Erhardt S; Landen M; Sellgren CM
Nat Commun; 2022 Nov; 13(1):6427. PubMed ID: 36329007
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the impact of complement component 4A in bipolar disorder.
Hörbeck E; Jonsson L; Malwade S; Karlsson R; Pålsson E; Sigström R; Sellgren CM; Landén M
Brain Behav Immun; 2024 Feb; 116():150-159. PubMed ID: 38070620
[TBL] [Abstract][Full Text] [Related]
4. Altered CSMD1 Expression Alters Cocaine-Conditioned Place Preference: Mutual Support for a Complex Locus from Human and Mouse Models.
Drgonova J; Walther D; Singhal S; Johnson K; Kessler B; Troncoso J; Uhl GR
PLoS One; 2015; 10(7):e0120908. PubMed ID: 26171607
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of the CSMD1 gene in the peripheral blood of schizophrenia patients.
Liu Y; Fu X; Tang Z; Li C; Xu Y; Zhang F; Zhou D; Zhu C
BMC Psychiatry; 2019 Apr; 19(1):113. PubMed ID: 30987620
[TBL] [Abstract][Full Text] [Related]
6. Complement component 4A protein levels are negatively related to frontal volumes in patients with schizophrenia spectrum disorders.
Gangadin SS; Germann M; de Witte LD; Gelderman KA; Mandl RCW; Sommer IEC
Schizophr Res; 2023 Nov; 261():6-14. PubMed ID: 37678145
[TBL] [Abstract][Full Text] [Related]
7. Multi-ancestry phenome-wide association of complement component 4 variation with psychiatric and brain phenotypes in youth.
Hernandez LM; Kim M; Zhang P; Bethlehem RAI; Hoftman G; Loughnan R; Smith D; Bookheimer SY; Fan CC; Bearden CE; Thompson WK; Gandal MJ
Genome Biol; 2023 Mar; 24(1):42. PubMed ID: 36882872
[TBL] [Abstract][Full Text] [Related]
8. CSMD1 regulates brain complement activity and circuit development.
Baum ML; Wilton DK; Fox RG; Carey A; Hsu YH; Hu R; Jäntti HJ; Fahey JB; Muthukumar AK; Salla N; Crotty W; Scott-Hewitt N; Bien E; Sabatini DA; Lanser TB; Frouin A; Gergits F; Håvik B; Gialeli C; Nacu E; Lage K; Blom AM; Eggan K; McCarroll SA; Johnson MB; Stevens B
Brain Behav Immun; 2024 Jul; 119():317-332. PubMed ID: 38552925
[TBL] [Abstract][Full Text] [Related]
9. Biallelic variants in CSMD1 are implicated in a neurodevelopmental disorder with intellectual disability and variable cortical malformations.
Werren EA; Peirent ER; Jantti H; Guxholli A; Srivastava KR; Orenstein N; Narayanan V; Wiszniewski W; Dawidziuk M; Gawlinski P; Umair M; Khan A; Khan SN; Geneviève D; Lehalle D; van Gassen KLI; Giltay JC; Oegema R; van Jaarsveld RH; Rafiullah R; Rappold GA; Rabin R; Pappas JG; Wheeler MM; Bamshad MJ; Tsan YC; Johnson MB; Keegan CE; Srivastava A; Bielas SL
Cell Death Dis; 2024 May; 15(5):379. PubMed ID: 38816421
[TBL] [Abstract][Full Text] [Related]
10. Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up.
Hidalgo-Figueroa M; Salazar A; Romero-López-Alberca C; MacDowell KS; García-Bueno B; Bioque M; Bernardo M; Parellada M; González-Pinto A; García-Portilla MP; Lobo A; Rodriguez-Jimenez R; Berrocoso E; Leza JC; ;
Int J Neuropsychopharmacol; 2023 Nov; 26(11):796-807. PubMed ID: 37603404
[TBL] [Abstract][Full Text] [Related]
11. Complement system biomarkers in first episode psychosis.
Kopczynska M; Zelek W; Touchard S; Gaughran F; Di Forti M; Mondelli V; Murray R; O'Donovan MC; Morgan BP
Schizophr Res; 2019 Feb; 204():16-22. PubMed ID: 29279246
[TBL] [Abstract][Full Text] [Related]
12. Peripheral and central biomarkers associated with inflammation in antipsychotic naïve first episode psychosis: Pilot studies.
Cadenhead KS; Mirzakhanian H; Achim C; Reyes-Madrigal F; de la Fuente-Sandoval C
Schizophr Res; 2024 Feb; 264():39-48. PubMed ID: 38091871
[TBL] [Abstract][Full Text] [Related]
13. Central insulin dysregulation in antipsychotic-naïve first-episode psychosis: In silico exploration of gene expression signatures.
Lee J; Xue X; Au E; McIntyre WB; Asgariroozbehani R; Tseng GC; Papoulias M; Panganiban K; Agarwal SM; Mccullumsmith R; Freyberg Z; Logan RW; Hahn MK
Psychiatry Res; 2024 Jan; 331():115636. PubMed ID: 38104424
[TBL] [Abstract][Full Text] [Related]
14. The usefulness of a complete blood count in the prediction of the first episode of schizophrenia diagnosis and its relationship with oxidative stress.
Juchnowicz D; Dzikowski M; Rog J; Waszkiewicz N; Karakuła KH; Zalewska A; Maciejczyk M; Karakula-Juchnowicz H
PLoS One; 2023; 18(10):e0292756. PubMed ID: 37824542
[TBL] [Abstract][Full Text] [Related]
15. Genetic Variants in CSMD1 Gene Are Associated with Cognitive Performance in Normal Elderly Population.
Stepanov V; Marusin A; Vagaitseva K; Bocharova A; Makeeva O
Genet Res Int; 2017; 2017():6293826. PubMed ID: 29379655
[TBL] [Abstract][Full Text] [Related]
16. Rare mutations in the complement regulatory gene CSMD1 are associated with male and female infertility.
Lee AS; Rusch J; Lima AC; Usmani A; Huang N; Lepamets M; Vigh-Conrad KA; Worthington RE; Mägi R; Wu X; Aston KI; Atkinson JP; Carrell DT; Hess RA; O'Bryan MK; Conrad DF
Nat Commun; 2019 Oct; 10(1):4626. PubMed ID: 31604923
[TBL] [Abstract][Full Text] [Related]
17. Glucose dysregulation in antipsychotic-naive first-episode psychosis: in silico exploration of gene expression signatures.
Lee J; Xue X; Au E; McIntyre WB; Asgariroozbehani R; Panganiban K; Tseng GC; Papoulias M; Smith E; Monteiro J; Shah D; Maksyutynska K; Cavalier S; Radoncic E; Prasad F; Agarwal SM; Mccullumsmith R; Freyberg Z; Logan RW; Hahn MK
Transl Psychiatry; 2024 Jan; 14(1):19. PubMed ID: 38199991
[TBL] [Abstract][Full Text] [Related]
18. Association of elevated levels of peripheral complement components with cortical thinning and impaired logical memory in drug-naïve patients with first-episode schizophrenia.
Yu H; Ni P; Tian Y; Zhao L; Li M; Li X; Wei W; Wei J; Wang Q; Guo W; Deng W; Ma X; Coid J; Li T
Schizophrenia (Heidelb); 2023 Nov; 9(1):79. PubMed ID: 37935744
[TBL] [Abstract][Full Text] [Related]
19. Taurine and Epidermal Growth Factor Belong to the Signature of First-Episode Psychosis.
Koido K; Innos J; Haring L; Zilmer M; Ottas A; Vasar E
Front Neurosci; 2016; 10():331. PubMed ID: 27471446
[TBL] [Abstract][Full Text] [Related]
20. Soluble terminal complement complex blood levels are elevated in schizophrenia.
Savukoski S; Mannes M; Wohlgemuth L; Schultze A; Guest PC; Meyer-Lotz G; Dobrowolny H; Relja B; Huber-Lang M; Steiner J
Eur Arch Psychiatry Clin Neurosci; 2024 Jan; ():. PubMed ID: 38243017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
